Login / Signup

Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient.

Linda BrokāneInta JaunalksneAndra TilgaseEvija OlmaneDonatas PetroškaAgnija RasaPēteris Alberts
Published in: Clinical case reports (2019)
A 35-year-old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivolumab and Rigvir. Subsequently, the progression has slowed.
Keyphrases
  • case report
  • multiple sclerosis
  • early stage
  • radiation therapy
  • soft tissue
  • squamous cell carcinoma
  • radiation induced
  • rectal cancer